Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Puma Biotechnology Inc shares valued at $90,909 were sold by Cesano Alessandra on Jul 18 ’25. At $3.37 per share, Cesano Alessandra sold 27,000 shares. The insider’s holdings dropped to 41,850 shares worth approximately $0.22 million following the completion of this transaction.
Also, Cesano Alessandra purchased 27,000 shares, netting a total of over 90,909 in proceeds.
Before that, NOUGUES MAXIMO F had sold 5,587 shares from its account. In a trade valued at $19,739, the Chief Financial Officer traded Puma Biotechnology Inc shares for $3.53 each. Upon closing the transaction, the insider’s holdings decreased to 5,587 shares, worth approximately $1.09 million.
As published in a research note from Citigroup on September 28, 2021, Puma Biotechnology Inc [PBYI] has been rated up from a Neutral to a Buy and the price target has been revised to $11. As of October 08, 2019, Goldman has decreased its “Neutral” rating to a “Sell” for PBYI. Earlier on May 10, 2019, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for PBYI stock which previously was a “a Buy”.
Analyzing PBYI Stock Performance
On last trading session, Puma Biotechnology Inc [NASDAQ: PBYI] rose 2.15% to $5.22. The stock’s lowest price that day was $5.075, but it reached a high of $5.39 in the same session. During the last five days, there has been a drop of approximately -1.88%. Over the course of the year, Puma Biotechnology Inc shares have jumped approximately 84.45%. Shares of the company reached a 52-week high of $6.07 on 08/18/25 and a 52-week low of $2.58 on 04/09/25.
Support And Resistance Levels for Puma Biotechnology Inc (PBYI)
According to the 24-hour chart, there is a support level at 5.06, which, if violated, would cause prices to drop to 4.91. In the upper region, resistance lies at 5.39. The next price resistance is at 5.56. RSI (Relative Strength Index) is 70.14 on the 14-day chart, showing overbought technical sentiment.
Is Puma Biotechnology Inc subject to short interest?
Stocks of Puma Biotechnology Inc saw a sharp rise in short interest on 2025-07-31 jumping by 0.15 million shares to 2.78 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 2.63 million shares. A jump of 5.42% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.54 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.54.
